The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Dysregulation of apoptosis in hepatocellular carcinoma cells
Open accessAbstract
Hepatocellular carcinoma (HCC) is a major health problem, being the sixth most common cancer world-wide. Dysregulation of the balance between proliferation and cell death represents a pro-tumorigenic principle in human hepatocarcinogenesis. This review updates the recent relevant contributions reporting molecular alterations for HCC that induce an imbalance in the regulation of apoptosis. Alterations in the expression and/or activation of p53 are frequent in HCC cells, which confer on them resistance to chemotherapeutic drugs. Many HCCs are also insensitive to apoptosis induced either by death receptor ligands, such as FasL or TRAIL, or by transforming growth factor-beta (TGF-beta). Although the expression of some pro-apoptotic genes is decreased, the balance between death and survival is dysregulated in HCC mainly due to overactivation of anti-apoptotic pathways. Indeed, some molecules involved in counteracting apoptosis, such as Bcl-X(L), Mcl-1, c-IAP1, XIAP or survivin are over-expressed in HCC cells. Furthermore, some growth factors that mediate cell survival are up-regulated in HCC, as well as the molecules involved in the machinery responsible for cleavage of their pro-forms to an active peptide. The expression and/or activation of the JAK/STAT, PI3K/AKT and RAS/ERKs pathways are enhanced in many HCC cells, conferring on them resistance to apoptotic stimuli. Finally, recent evidence indicates that inflammatory processes, as well as the epithelial-mesenchymal transitions that occur in HCC cells to facilitate their dissemination, are related to cell survival. Therefore, therapeutic strategies to selectively inhibit anti-apoptotic signals in liver tumor cells have the potential to provide powerful tools to treat HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Waris, G., Turkson, J., Hassanein, T., & Siddiqui, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1569-1580.2005 · Cited by 157
RetractedMassagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Liu, L., Cao, Y., Chen, C., Zhang, X., McNabola, A., Wilkie, D., Wilhelm, S., Lynch, M., & Carter, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1377 · Cited by 1,536
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Molecular targeted therapies in hepatocellular carcinoma†
Llovet, J. M., & Bruix, J. (2008) · Hepatology · doi:10.1002/hep.22506 · Cited by 1,004
Snail blocks the cell cycle and confers resistance to cell death
Vega, S., Morales, A. V., Ocaña, O. H., Valdés, F., Fabregat, I., & Nieto, M. A. (2004) · Genes & Development · doi:10.1101/gad.294104 · Cited by 867
Self-citationThe TRAIL apoptotic pathway in cancer onset, progression and therapy
Johnstone, R. W., Frew, A. J., & Smyth, M. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2465 · Cited by 834
Novel advancements in the management of hepatocellular carcinoma in 2008
Llovet, J. M., & Bruix, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.022 · Cited by 815
Yoshikawa, H., Matsubara, K., Qian, G.-S., Jackson, P., Groopman, J. D., Manning, J. E., Harris, C. C., & Herman, J. G. (2001) · Nature Genetics · doi:10.1038/ng0501-29 · Cited by 722
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Conner, E. A., Lee, J., Factor, V. M., & Thorgeirsson, S. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.006 · Cited by 710
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420513 · Cited by 698
Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., & Schulte-Hermann, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5408 · Cited by 668
NF-κB and cancer — identifying targets and mechanisms
Naugler, W. E., & Karin, M. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.020 · Cited by 636
Hussain, S. P., Schwank, J., Staib, F., Wang, X. W., & Harris, C. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210279 · Cited by 621
Gong, G., Waris, G., Tanveer, R., & Siddiqui, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171311298 · Cited by 584
Apoptosis: a mechanism of acute and chronic liver injury
Guicciardi, M. E., & Gores, G. J. (2005) · Gut · doi:10.1136/gut.2004.053850 · Cited by 514
Siegel, A. B., Cohen, E. I., Ocean, A., Lehrer, D., Goldenberg, A., Knox, J. J., Chen, H., Clark-Garvey, S., Weinberg, A., Mandeli, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9947 · Cited by 506
WNT/β‐catenin signaling in liver health and disease
Thompson, M. D., & Monga, S. P. S. (2007) · Hepatology · doi:10.1002/hep.21651 · Cited by 471
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Lee, J.-S., Conner, E. A., Schroeder, I., Factor, V. M., & Thorgeirsson, S. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31457 · Cited by 393
Dysregulation of growth factor signaling in human hepatocellular carcinoma
Breuhahn, K., Longerich, T., & Schirmacher, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209556 · Cited by 391
Llovet, J. M., Chen, Y., Wurmbach, E., Roayaie, S., Fiel, M. I., Schwartz, M., Thung, S. N., Khitrov, G., Zhang, W., Villanueva, A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.014 · Cited by 386
Petrocca, F., Vecchione, A., & Croce, C. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1768 · Cited by 385
Niwa, Y., Kanda, H., Shikauchi, Y., Saiura, A., Matsubara, K., Kitagawa, T., Yamamoto, J., Kubo, T., & Yoshikawa, H. (2005) · Oncogene · doi:10.1038/sj.onc.1208788 · Cited by 339
Coulouarn, C., Factor, V. M., & Thorgeirsson, S. S. (2008) · Hepatology · doi:10.1002/hep.22283 · Cited by 332
Survivin promotes cell proliferation in human hepatocellular carcinoma
Ito, T., Shiraki, K., Sugimoto, K., Yamanaka, T., Fujikawa, K., Ito, M., Takase, K., Moriyama, M., Kawano, H., Hayashida, M., et al. (2000) · Hepatology · doi:10.1053/he.2000.6496 · Cited by 329
Waris, G., Huh, K.-W., & Siddiqui, A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7721-7730.2001 · Cited by 318
Carr, B. I., Hayashi, I., Branum, E. L., & Moses, H. L. (1986) · PubMed · Cited by 310
NF-κB signaling, liver disease and hepatoprotective agents
Sun, B., & Karin, M. (2008) · Oncogene · doi:10.1038/onc.2008.300 · Cited by 307
TACE is required for the activation of the EGFR by TGF-α in tumors
Borrell-Pagès, M., Rojo, F., Albanell, J., Baselga, J., & Arribas, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg111 · Cited by 274
Leng, J., Han, C., Demetris, J. A., Michalopoulos, G. K., & Wu, T. (2003) · Hepatology · doi:10.1053/jhep.2003.50380 · Cited by 258
Turley, E. A., Veiseh, M., Radisky, D. C., & Bissell, M. J. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1089 · Cited by 253
Fransvea, E., Angelotti, U., Antonaci, S., & Giannelli, G. (2008) · Hepatology · doi:10.1002/hep.22201 · Cited by 253
Valdés, F., Alvarez, A. M., Locascio, A., Vega, S., Herrera, B. M., Fernández, M., Benito, M., Nieto, M. A., & Fabregat, I. (2002) · PubMed · Cited by 249
Self-citationExpression and Role of Bcl–Xl in Human Hepatocellular Carcinomas
Takehara, T., Liu, X., Fujimoto, J., Friedman, S. L., & Takahashi, H. (2001) · Hepatology · doi:10.1053/jhep.2001.25387 · Cited by 246
Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy
Sieghart, W., Losert, D., Strommer, S., Cejka, D., Schmid, K., Rasoul-Rockenschaub, S., Bodingbauer, M., Crevenna, R., Monia, B. P., Peck-Radosavljevic, M., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.010 · Cited by 244
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K.-I., Sata, M., Kohara, M., & Yoshimura, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012127 · Cited by 236
Fausto, N. (1993) · Hepatology · doi:10.1016/0270-9139(93)90250-q · Cited by 229
Survival and apoptosis: a dysregulated balance in liver cancer
Fabregat, I., Roncero, C., & Fernández, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2006.01409.x · Cited by 225
Self-citationHuang, S., He, X., Ding, J., Liang, L., Zhao, Y., Zhang, Z., Yao, X., Pan, Z., Zhang, P., Li, J., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23580 · Cited by 204
Chemotherapeutic Agents Augment TRAIL-Induced Apoptosis in Human Hepatocellular Carcinoma Cell Lines
Yamanaka, T., Shiraki, K., Sugimoto, K., Ito, T., Fujikawa, K., Ito, M., Takase, K., Moriyama, M., Nakano, T., & Suzuki, A. (2000) · Hepatology · doi:10.1053/jhep.2000.16266 · Cited by 199
Ogata, H., Kobayashi, T., Chinen, T., Takaki, H., Sanada, T., Minoda, Y., Koga, K., Takaesu, G., Maehara, Y., Iida, M., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.025 · Cited by 183
Kern, M. (2002) · Hepatology · doi:10.1016/s0270-9139(02)00094-0 · Cited by 170
Ganten, T. M., Koschny, R., Haas, T. L., Sykora, J., Li-Weber, M., Herzer, K., & Walczak, H. (2005) · Hepatology · doi:10.1002/hep.20807 · Cited by 170
Yoshida, T., Hisamoto, T., Akiba, J., Koga, H., Nakamura, K., Tokunaga, Y., Hanada, S., Kumemura, H., Maeyama, M., Harada, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209635 · Cited by 169
Nuclear factor-κB and liver carcinogenesis
Arsura, M., & Cavin, L. G. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.008 · Cited by 169
Kern, M. A., Haugg, A. M., Koch, A. F., Schilling, T., Breuhahn, K., Walczak, H., Fleischer, B., Trautwein, C., Michalski, C., Schulze-Bergkamen, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0325 · Cited by 168
Wnt/frizzled signaling in hepatocellular carcinoma
Lee, H. C., Kim, M., & Wands (2006) · Frontiers in bioscience · doi:10.2741/1933 · Cited by 164
Fischer, A. N. M., Fuchs, E., Mikula, M., Huber, H., Beug, H., & Mikulits, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210121 · Cited by 162
Nitta, T., Kim, J.-S., Mohuczy, D., & Behrns, K. E. (2008) · Hepatology · doi:10.1002/hep.22397 · Cited by 161
Reffey, S. B., Würthner, J., Parks, W. T., Roberts, A. B., & Duckett, C. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100331200 · Cited by 153
Ito, N., Kawata, S., Tamura, S., Takaishi, K., Shirai, Y., Kiso, S., Yabuuchi, I., Matsuda, Y., Nishioka, M., & Tarui, S. (1991) · PubMed · Cited by 152
PIK3IP1, a Negative Regulator of PI3K, Suppresses the Development of Hepatocellular Carcinoma
He, X., Zhu, Z., Johnson, C., Stoops, J. W., Eaker, A. E., Bowen, W. C., & DeFrances, M. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0025 · Cited by 145
Yang, Y.-A., Zhang, G., Feigenbaum, L., & Zhang, Y. E. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.025 · Cited by 143
Involvement of EGF receptor and c-Src in the survival signals induced by TGF-β1 in hepatocytes
Murillo, M. M., del Castillo, G., Sánchez, A., Fernández, M., & Fabregat, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208664 · Cited by 140
Self-citationOkano, H., Shiraki, K., Inoue, H., Kawakita, T., Yamanaka, T., Deguchi, M., Sugimoto, K., Sakai, T., Ohmori, S., Fujikawa, K., et al. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000079328.76631.28 · Cited by 132
Calvisi, D. F., Pinna, F., Meloni, F., Ladu, S., Pellegrino, R., Sini, M., Daino, L., Simile, M. M., Miglio, M. R. D., Virdis, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6157 · Cited by 130
Ladu, S., Calvisi, D. F., Conner, E. A., Farina, M., Factor, V. M., & Thorgeirsson, S. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.012 · Cited by 129
Pathil, A., Armeanu, S., Venturelli, S., Mascagni, P., Weiß, T. S., Gregor, M., Lauer, U. M., & Bitzer, M. (2006) · Hepatology · doi:10.1002/hep.21054 · Cited by 126
Suzuki, A., Hayashida, M., Kawano, H., Sugimoto, K., Nakano, T., & Shiraki, K. (2000) · Hepatology · doi:10.1053/jhep.2000.17738 · Cited by 123
Farazi, P. A., Glickman, J. N., Horner, J. W., & DePinho, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4608 · Cited by 119
Cyclooxygenases in hepatocellular carcinoma
Cervello, M., & Montalto, G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i32.5113 · Cited by 116
Kaur, S., Wang, F., Manickam, V., & Arsura, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505671200 · Cited by 112
Kitisin, K., Ganesan, N., Tang, Y., Jogunoori, W. S., Volpe, E., Kim, S. S., Katuri, V., Kallakury, B., Pishvaian, M. J., Albanese, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210513 · Cited by 109
Shi, Y., Ding, W., Zhou, J., He, J., Xu, Y., Gambotto, A. A., Rabinowich, H., Fan, J., & Yin, X. (2008) · Hepatology · doi:10.1002/hep.22393 · Cited by 107
Murillo, M. M., Carmona‐Cuenca, I., del Castillo, G., Ortiz, C., Roncero, C., Sánchez, A., Fernández, M., & Fabregat, I. (2007) · Biochemical Journal · doi:10.1042/bj20061846 · Cited by 107
Self-citationIkezoe, T., Nishioka, C., Tasaka, T., Yang, Y., Komatsu, N., Togitani, K., Koeffler, H. P., & Taguchi, H. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0071 · Cited by 101
Caja, L., Ortiz, C., Bertrán, E., Murillo, M. M., Miró-Obradors, M. J., Palacios, E., & Fabregat, I. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.09.002 · Cited by 94
Self-citationDu, J., Liang, X., Liu, Y., Qu, Z., Gao, L., Han, L., Liu, S., Cui, M., Shi, Y., Zhang, Z., et al. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.144 · Cited by 92
Carmona‐Cuenca, I., Herrera, B. M., Ventura, J., Roncero, C., Fernández, M., & Fabregat, I. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20568 · Cited by 91
Self-citationChoudhari, S. R., Khan, M. A., Harris, G., Picker, D., Jacob, G. S., Block, T., & Shailubhai, K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0561 · Cited by 90
Sato, Y., Kato, J., Takimoto, R., Takada, K., Kawano, Y., Miyanishi, K., Kobune, M., Sato, Y., Takayama, T., Matunaga, T., et al. (2006) · Gut · doi:10.1136/gut.2005.070417 · Cited by 88
Fabregat, I., Herrera, B. M., Fernández, M., Alvarez, A. M., Sánchez, A., Roncero, C., Ventura, J., Valverde, Á. M., & Benito, M. (2000) · Hepatology · doi:10.1053/jhep.2000.9774 · Cited by 85
Self-citationADAM17 mRNA expression and pathological features of hepatocellular carcinoma
Ding, X., 杨连粤, Huang, G.-W., Wang, W., & Lu, W.-Q. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i18.2735 · Cited by 83
VEGF signaling inhibitors: More pro-apoptotic than anti-angiogenic
Epstein, R. J. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9071-1 · Cited by 82
pp60c-src Activation in hepatocellular carcinoma of humans and LEC rats
Masaki, T., Okada, M., Shiratori, Y., Rengifo, W., Matsumoto, K., Maeda, S., Kato, N., Kanai, F., Komatsu, Y., Nishioka, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270511 · Cited by 79
Kim, Y. C., Song, K.-S., Yoon, G., Nam, M., & Ryu, W. (2001) · Oncogene · doi:10.1038/sj.onc.1203840 · Cited by 77
Miyoshi, H., Fujie, H., Shintani, Y., Tsutsumi, T., Shinzawa, S., Maku-uchi, M., Kokudo, N., Matsuura, Y., Suzuki, T., Miyamura, T., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.028 · Cited by 76
Baek, H. J., Lim, S., Kitisin, K., Jogunoori, W. S., Tang, Y., Marshall, M. B., Mishra, B., Kim, T. H., Cho, K. H., Kim, S. S., et al. (2008) · Hepatology · doi:10.1002/hep.22460 · Cited by 73
Qiao, L., Zhang, H., Yu, J. Q., Francisco, R., Dent, P., Ebert, M. P., Röcken, C., & Farrell, G. C. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.280 · Cited by 73
Kusaba, M., Nakao, K., Goto, T., Nishimura, D., Kawashimo, H., Shibata, H., Motoyoshi, Y., Taura, N., Ichikawa, T., Hamasaki, K., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.017 · Cited by 68
Lian, Z., Liu, J., Li, L., Li, X., Clayton, M. M., Wu, M., Wang, H., Arbuthnot, P. B., Kew, M. C., Fan, D., et al. (2006) · Hepatology · doi:10.1002/hep.21053 · Cited by 61
Valdés, F., Murillo, M. M., Valverde, Á. M., Herrera, B. M., Sánchez, A., Benito, M., Fernández, M., & Fabregat, I. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.08.015 · Cited by 59
Self-citationChen, G. G., Lai, P. B. S., Chan, P. K. S., Chak, E. C. W., Yip, J. H. Y., Ho, R. L. K., Leung, B. C. S., & Lau, W. Y. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00182-4 · Cited by 55
Overexpression of Bcl-2 protects human hepatoma cells from Fasantibody-mediated apoptosis
Takahashi, M., Saito, H., Okuyama, T., Miyashita, T., Kosuga, M., Sumisa, F., Yamada, M., Ebinuma, H., & Ishii, H. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80230-x · Cited by 50
Lian, Z., Liu, J., Pan, J., Şatıroğlu-Tufan, N. L., Zhu, M.-H., Arbuthnot, P. B., Kew, M. C., Clayton, M. M., & Feitelson, M. A. (2001) · Hepatology · doi:10.1053/jhep.2001.25545 · Cited by 49
BRE is an antiapoptotic protein in vivo and overexpressed in human hepatocellular carcinoma
Chan, B., Ching, A. K.-K., To, K., Leung, J. C. K., Chen, S., Li, Q., Lai, P. B. S., Tang, N. L. S., Shaw, P.-C., Chan, J. Y. H., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210733 · Cited by 45
Expression of Fas-related genes in human hepatocellular carcinomas
Shin, E., Shin, J., Park, J. H., Kim, J.-J., Kim, H., & Kim, S. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00251-1 · Cited by 43
Ortiz, C., Caja, L., Sancho, P., Bertrán, E., & Fabregat, I. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.02.015 · Cited by 41
Self-citationOn the TRAIL to therapeutic intervention in liver disease
Herr, I., Schemmer, P., & Büchler, M. W. (2007) · Hepatology · doi:10.1002/hep.21740 · Cited by 41
Piercing the armor of hepatobiliary cancer: Bcl-2 homology domain 3 (BH3) mimetics and cell death
Mott, J. L., & Gores, G. J. (2007) · Hepatology · doi:10.1002/hep.21812 · Cited by 41
Huether, A., Höpfner, M., Sutter, A. P., Baradari, V., Schuppan, D., & Scherübl, H. (2006) · Europe PMC (PubMed Central) · doi:10.3748/wjg.v12.i32.5160 · Cited by 37
Chen, X., He, S., Wang, H., Zhao, Y.-Z., & Zhang, W. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i11.2433 · Cited by 34
NFκB‐mediated upregulation of bcl‐xl restrains TRAIL‐mediated apoptosis in murine viral hepatitis†
Zender, L., Hütker, S., Mundt, B., Waltemathe, M., Klein, C., Trautwein, C., Malek, N. P., Manns, M. P., Kühnel, F., & Kubicka, S. (2005) · Hepatology · doi:10.1002/hep.20566 · Cited by 34
Toni, E. N. D., Kuntzen, C., Gerbes, A. L., Thasler, W. E., Sonuc, N., Mucha, S. R., Čamaj, P., Bruns, C. J., Göke, B., & Eichhorst, S. T. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.010 · Cited by 30
Cited by
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
Biosensors: the new wave in cancer diagnosis
Mousa, S. (2010) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s13465 · Cited by 381
Metadata
- Authors
- Fabregat, I.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2009
- Volume
- 15
- Issue
- 5
- Pages
- 513
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2161818053
- Cited by
- 280
- References
- 94
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.